Our data suggest that the NLRP3 inflammasome and the S1P signalling system could represent potential contributors to pathology and therefore putative therapeutic targets in CF, COPD and other muco-obstructive respiratory diseases. The gene discussed is NLRP3; the disease is cystic fibrosis.